Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Nuevos datos de Sanidad muestran que combinar Pfizer con AstraZeneca genera una inmunidad celular muy potente

NIUS, 02 Jun 2021

Los resultados del estudio CombivacS indican "un aumento de cuatro veces en la respuesta inmune celular" tras inocular Pfizer…

Piccolo vademecum sul vaccino AstraZeneca - Galileo

Galileonet, 20 Mar 2021

di Anna Lisa Bonfranceschi e Sandro Jannaccone Sono giornate bollenti per AstraZeneca e il suo vaccino, sviluppato in…

5 things you need to know about the AstraZeneca vaccine.

infosurhoy, 17 Feb 2021

The Therapeutic Goods Administration (TGA) yesterday announced it has provisionally approved AstraZeneca’s COVID vaccine for…

5 things you need to know about the AstraZeneca vaccine

MedicalXpress, 17 Feb 2021

Credit: Pixabay/CC0 Public Domain The Therapeutic Goods Administration (TGA) yesterday announced it has provisionally approved…

MIL-Evening Report: 5 things you need to know about the AstraZeneca vaccine now the...

Foreign Affairs New Zealand, 17 Feb 2021

Article sponsored by – By Kirsty Wilson, Postdoctoral Research Fellow, RMIT University The Therapeutic Goods Administration (TGA…

5 things you need to know about AstraZeneca vaccine now TGA has approved it for use in Australia

Mirage News, 17 Feb 2021

The Therapeutic Goods Administration (TGA) yesterday announced it has provisionally approved AstraZeneca’s COVID vaccine for…

5 things you need to know about the AstraZeneca vaccine now the TGA has approved it for use in Australia

The Conversation, 17 Feb 2021

The Therapeutic Goods Administration (TGA) yesterday announced it has provisionally approved AstraZeneca’s COVID vaccine for…

COVID-19: How do viral vector vaccines work?

Medical News Today, 15 Jan 2021

Unlike many other vaccines that contain an infectious pathogen or a part of it, viral vector vaccines use a harmless virus to…

Oxford Covid-19 vaccine stimulates broad antibody and T cell functions – study

Irish Examiner, 25 Dec 2020

The University of Oxford’s coronavirus vaccine stimulates broad antibody and T cell responses, published trial results show.

Oxford vaccine stimulates broad antibody and T cell functions

SelectScience, 21 Dec 2020

Researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19…

Oxford vaccine stimulates broad antibody and T cell functions

The FINANCIAL, 19 Dec 2020

The FINANCIAL -- Researchers from the University of Oxford have published further data from the Phase I/II clinical trials of…

Oxford says vaccine has good immune response with two dose regime

The Hindu, 18 Dec 2020

Oxford’s COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose…

Oxford vaccine stimulates broad antibody and T cell functions

MedicalXpress, 18 Dec 2020

Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1…

Two doses of Covid vaccine more effective: Oxford

News Today, 18 Dec 2020

Chennai: Oxford’s Covid-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full…

COVID: Oxford on vaccine doses

Times of India, 18 Dec 2020

Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose…

Oxford's COVID-19 vaccine has better immune response with two-dose regime

Dailyhunt, 18 Dec 2020

London: Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-d…

COVID-19: Oxford says vaccine has good immune response with two-dose regime

Times of India, 18 Dec 2020

Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose…

COVID: Oxford on vaccine doses

Times of India, 18 Dec 2020

Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose…

COVID-19 vaccine has good immune response with 2-dose regime: Oxford University

Dailyhunt, 18 Dec 2020

Washington, Dec 18: In a recent development, Oxford University on Thursday said that its COVID-19 vaccine candidate has a…

COVID-19 vaccine has good immune response with 2-dose regime: Oxford University

Oneindia, 18 Dec 2020

In a recent development, Oxford University on Thursday said that its COVID-19 vaccine candidate has a better immune response…

COVID-19 vaccine candidate has good immune response with two full-dose regime, says Oxford

Business Today India, 18 Dec 2020

Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose…

Oxford says vaccine has good immune response with two-dose regime - ET HealthWorld

Times of India, 18 Dec 2020

LONDON: Oxford's Covid-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-d…

Trial data confirms two doses of Oxford/ AstraZeneca COVID vaccine are better than one

Scimex, 18 Dec 2020

Having two doses of the Oxford/ AstraZeneca COVID vaccine known as, ChAdOx1 nCoV-19, produces a better immune response than a…

Oxford Says Vaccine Has Good Immune Response With Two-Dose Regimen

Medscape, 18 Dec 2020

LONDON (Reuters) - Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose regimen is used rather…

UK COVID-19 Update: Long COVID Guidance, GPs' 'Spare Jabs'

Medscape, 18 Dec 2020

These are the UK coronavirus stories you need to know about today. Long COVID Long COVID guidance was issued by the National…

Oxford vaccine stimulates broad antibody and T cell functions

FirstWord Pharma, 17 Dec 2020

Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1…

Oxford Covid-19 vaccine stimulates broad antibody and T cell functions – study

MSN, 17 Dec 2020

The University of Oxford’s coronavirus vaccine stimulates broad antibody and T cell responses, published trial results show.

Oxford Says Covid-19 Vaccine Has Good Immune Response With Two-dose Regime

News 18, 17 Dec 2020

Representational Image: AP The details from the Phase I/II clinical trials released on Thursday made no reference to the half-dos…

Oxford says vaccine has good immune response with two-dose regime

CTV News, 17 Dec 2020

LONDON -- Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a…

Oxford says vaccine has good immune response with two-dose...

Investing.com - UK, 17 Dec 2020

By Reuters Staff LONDON (Reuters) - Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose…

Oxford Vaccine Stimulates Broad Antibody and T-cell Functions

Technology Networks, 17 Dec 2020

Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1…

News story from Bridgwater Mercury on Thursday 17 December 2020

Bridgwater Mercury, 17 Dec 2020

News story from Braintree

Braintree & Witham Times, 17 Dec 2020

News story from Bournemoth Daily Echo on Thursday 17 December 2020

Bournemoth Daily Echo, 17 Dec 2020

News story from Bridport News on Thursday 17 December 2020

Bridport News, 17 Dec 2020

News story from The Whitehaven News on Thursday 17 December 2020

The Whitehaven News, 17 Dec 2020

Oxford Covid-19 vaccine stimulates broad antibody and T cell functions – study

Epping Forest Guardian, 17 Dec 2020

The University of Oxford’s coronavirus vaccine stimulates broad antibody and T cell responses, published trial results show.

News story from Gazetta on Thursday 17 December 2020

Gazetta, 17 Dec 2020

News story from Hereford Times on Thursday 17 December 2020

Hereford Times, 17 Dec 2020

News story from Telegraph

Telegraph & Argus, 17 Dec 2020

News story from The Northern Echo on Thursday 17 December 2020

The Northern Echo, 17 Dec 2020

Oxford Covid-19 vaccine stimulates broad antibody and T cell functions – study

Winsford Guardian, 17 Dec 2020

The University of Oxford’s coronavirus vaccine stimulates broad antibody and T cell responses, published trial results show.

News story from Westmorland Gazette on Thursday 17 December 2020

Westmorland Gazette, 17 Dec 2020

News story from The Press (York) on Thursday 17 December 2020

The Press (York), 17 Dec 2020

News story from The National: The Newspaper that Supports an Independent Scotland on Thursday 17 December 2020

The National: The Newspaper that Supports an Independent Scotland, 17 Dec 2020

News story from Wandsworth Times on Thursday 17 December 2020

Wandsworth Times, 17 Dec 2020

News story from Bracknell News on Thursday 17 December 2020

Bracknell News, 17 Dec 2020